Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
Press release
Avignon, June 5th, 2011
30.06.2011
| Total number of outstanding shares forming the capital - 5,004,935 ordinary shares under isin FR0000054694 - 1,405,996 preferred shares under ISIN FR0010833251 |
6,410,931 |
| Total number of outstanding shares forming the capital with voting rights - 5,004,935 ordinary shares under ISIN FR0000054694 - 0 shares from stock-options under ISIN FR0000054694 |
5,004,935 |
| Number of shares with double voting rights | 86,840 |
| Total number of gross voting rights | 5,091,775 |
| Number of shares without voting rights - 7,000 registered shares - 934 bearer shares in the frame of the liquidity contract |
- 7,934 |
| Total number of exercisable voting rights* | 5,083,841 |
*Real number of voting rights = total number of voting rights – number of shares without voting rights
If you would like to receive FINANCIAL information about Naturex by e-mail, go to: www.naturex.com
NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996
Number of shares in the capital: 6,410,931
- 5,004,935 ordinary shares (ISIN FR0000054694)
- 1,405,996 preferred shares (ISIN FR0000010833251)
Naturex is part of the CAC Small and Gaïa Indexes.
Naturex is eligible for the "long-only" DSS.
MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP
About Naturex
Naturex is the global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - and produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).
Naturex’s sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its positioning on specific products which constitute niche markets, thanks to strong sourcing capacity and sustained Research & Development.
Contacts
| Jacques Dikansky President and CEO Tel.: +33 (0)4 90 23 96 89 naturex@naturex.com Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Thierry Lambert Vice-President and CFO Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com Anne Catherine Bonjour Press Relations – Actus Finance Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
